Metal element alteration in the lung by cisplatin and CV247 administration.

[1]  M. Falasca,et al.  Metal-based antitumor compounds: beyond cisplatin. , 2019, Future medicinal chemistry.

[2]  Seung Hyeun Lee.  Chemotherapy for Lung Cancer in the Era of Personalized Medicine , 2018, Tuberculosis and respiratory diseases.

[3]  P. Dyson,et al.  The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions , 2018 .

[4]  G. Hegyi,et al.  Changes of essential element content and prevention of cisplatin induced oxidative stress in rat liver by CV247 administration , 2016 .

[5]  C. Granger.  Physiotherapy management of lung cancer. , 2016, Journal of physiotherapy.

[6]  F. Hayati,et al.  Prevention of cisplatin nephrotoxicity , 2015, Journal of nephropharmacology.

[7]  S. Fosså,et al.  Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study. , 2015, Anticancer research.

[8]  A. Blázovics,et al.  Protective effect of CV247 against cisplatin nephrotoxicity in rats , 2014, Human & experimental toxicology.

[9]  A. Blázovics,et al.  Cisplatin administration influences on toxic and non-essential element metabolism in rats. , 2014, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[10]  F. Maltais,et al.  Exercise-Based Rehabilitation for People with Lung Cancer , 2014 .

[11]  Chaojun Wang,et al.  Protective Effect of Metalloporphyrins against Cisplatin-Induced Kidney Injury in Mice , 2014, PloS one.

[12]  K. Szentmihályi,et al.  [Mineral content of some herbs and plant extracts with anti-inflammatory effect used in gastrointestinal diseases]. , 2013, Orvosi hetilap.

[13]  I. Wistuba,et al.  Tissue platinum concentration and tumor response in non-small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Obradovic,et al.  Lipid Peroxidative Damage on Cisplatin Exposure and Alterations in Antioxidant Defense System in Rat Kidneys: A Possible Protective Effect of Selenium , 2012, International journal of molecular sciences.

[15]  A. Seely,et al.  Selenium and Lung Cancer: A Systematic Review and Meta Analysis , 2011, PloS one.

[16]  Wei Wang,et al.  Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation. , 2010, Biochemical pharmacology.

[17]  R. Moreno-Sánchez,et al.  Targeting of cancer energy metabolism. , 2009, Molecular nutrition & food research.

[18]  G. Deray,et al.  Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care , 2008, Cancer Chemotherapy and Pharmacology.

[19]  Yingjun Liao,et al.  Selection of agents for prevention of cisplatin-induced hepatotoxicity. , 2008, Pharmacological research.

[20]  Y. Itoh,et al.  Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. , 2006, Free radical biology & medicine.

[21]  S. Godward,et al.  Dietary advice combined with a salicylate, mineral and vitamin supplement (CV247) has some tumour static properties: a phase II study , 2005 .

[22]  M. Nazıroğlu,et al.  Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. , 2004, Toxicology.

[23]  G. Ramesh,et al.  Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. , 2004, Kidney international.

[24]  P. Vinkler,et al.  Metabolic Alterations of Toxic and Nonessential Elements by the Treatment of Sempervivum tectorum Extract in a Hyperlipidemic Rat Model , 2004, Toxicologic pathology.

[25]  N. Secher,et al.  Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin , 2003, British Journal of Cancer.

[26]  R. Bose.  Biomolecular targets for platinum antitumor drugs. , 2002, Mini reviews in medicinal chemistry.

[27]  B. D. de Martinis,et al.  Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. , 2001, Pharmacological research.

[28]  D. Sleijfer,et al.  Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer , 2000, The Lancet.

[29]  J. Féher,et al.  Antioxidant defense in erythrocytes and plasma of patients with active and quiescent Crohn disease and ulcerative colitis: a chemiluminescent study. , 1999, Clinical chemistry.

[30]  C. Bokemeyer,et al.  Cisplatin nephrotoxicity and protection by silibinin. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  V. Torri,et al.  Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P) , 1995 .

[32]  T. Ishikawa,et al.  Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. , 1993, The Journal of biological chemistry.

[33]  T. Cornelison,et al.  Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. , 1993, Gynecologic oncology.

[34]  D. Stewart,et al.  Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  P. Tothill,et al.  The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. , 1992, European journal of cancer.

[36]  R. Burk,et al.  Effect of selenium deficiency on the disposition of plasma glutathione. , 1985, Archives of biochemistry and biophysics.

[37]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.